U.S. Markets closed

Rafael Holdings to Report Fourth Quarter and Full Fiscal Year 2018 Results

NEWARK, N.J., Oct. 5, 2018 /PRNewswire/ -- Rafael Holdings, Inc., (NYSE American: RFL), has scheduled its report of fourth quarter and full fiscal year 2018 (the three and twelve months ended July 31, 2018) financial and operational results for Monday, October 15, 2018.

Rafael Holdings holds commercial real estate assets and interests in two clinical stage pharmaceutical companies. The pharmaceutical holdings consist of interests in Rafael Pharmaceuticals, Inc. and a majority stake in Lipomedix Pharmaceuticals Ltd., both of which are focused on development and commercialization of drugs in the oncology space. For more information, visit www.rafaelholdings.com (PRNewsfoto/Rafael Holdings, Inc.)

Rafael Holdings will issue an earnings release and post it on the Rafael Holdings investor relations website (http://rafaelholdings.irpass.com/) at 8:30 AM on October 15th. The Company will file its Form 10-K with the Securities and Exchange Commission later in the day on the 15th.

About Rafael Holdings, Inc.:
Rafael Holdings holds commercial real estate assets and interests in pharmaceutical companies.  The real estate holdings include properties in Newark and Piscataway, New Jersey and Jerusalem, Israel. The pharmaceutical holdings consist of interests in Rafael Pharmaceuticals, Inc. and a majority stake in Lipomedix Pharmaceuticals Ltd. Both are clinical-stage companies focused on the development and commercialization of oncology therapies. 

Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/rafael-holdings-to-report-fourth-quarter-and-full-fiscal-year-2018-results-300724999.html